Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Express Scripts Holding Co    ESRX

Delayed Quote. Delayed  - 08/26 10:00:00 pm
72.31 USD   +0.79%
08/25 NASDAQ 100 MOVE : Dltr, mu
08/24 LAWSUIT FOR LON : ESRX) Filed
08/18 EXPRESS SCRIPTS : Will your prescriptions be covered in 2017?
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Express Scripts Earnings Surged 74%; Forecast Clears Lowered Hurdle

share with twitter share with LinkedIn share with facebook
share via e-mail
0
02/18/2013 | 11:18pm CEST
   By Jon Kamp 
 

Pharmacy-benefit manager Express Scripts Holding Co. (>> Express Scripts Holding Co) reported a 74% surge in fourth-quarter earnings, helped by a major acquisition, while forecasting 2013 earnings mostly ahead of a Wall Street target the company helped drag lower three months ago.

The St. Louis-based company--which manages drug-benefit programs for health plans and corporate customers--rattled analysts in November when it said their forecasts for 2013 looked too high. Express Scripts didn't release its own guidance at the time, but said a still-weak economy was weighing on the number of prescriptions it handles.

Monday's release finally included company guidance for adjusted earnings of $4.20 to $4.30 per share this year. The target is largely above the $4.20 forecast among analysts surveyed by Thomson Reuters, although Express Scripts' November warning caused analysts to trim the consensus forecast by about 30 cents since then.

This will mark the first full year of combined operations for Express Scripts and Medco Health Solutions, which created the largest pharmacy-benefit manager, or PBM, following April's $29.1 billion Medco acquisition.

"2012 was a monumental year for Express Scripts as we closed the acquisition of Medco and made significant progress integrating the two companies," George Paz, Express Scripts' chief executive, said in a press release.

The company plans to hold a conference call Tuesday morning. Its shares are up about 2.9% so far this year, through Friday's close, trailing a 6.6% gain in the Standard & Poor's 500 index.

The company reported fourth-quarter earnings of $504.1 million, or 61 cents a share, up from $290.4 million, or 59 cents a share, a year earlier. Excluding deal-related costs and other items, per-share earnings rose to $1.05 from 82 cents.

Revenue more than doubled to $27.41 billion from the year-earlier period, which was before the Medco deal.

Analysts surveyed by Thomson Reuters had forecast earnings of $1.04 a share on sales of $27.24 billion. Analysts are forecasting lower sales in coming quarters as health insurer UnitedHealth Group Inc. (>> UnitedHealth Group Inc.) brings in-house the PBM business it had outsourced to Medco.

Express Scripts saw adjusted claims--a measure that takes into account monthly prescriptions filled in retail pharmacies and 90-day fills through the company's mail-order business--rise 111% in the recent quarter to 410.8 million.

The company's full-year adjusted claims tally about matched its target by nearing 1.4 billion. The company expects 5% to 7% growth in adjusted claims this year.

Its adjusted earnings forecast represents 12% to 15% growth.

Write to Jon Kamp at jon.kamp@dowjones.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

Stocks mentioned in the article : Express Scripts Holding Co, UnitedHealth Group Inc.
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on EXPRESS SCRIPTS HOLDING CO
08/25 NASDAQ 100 MOVERS : Dltr, mu
08/24 LAWSUIT FOR LONG-TERM INVESTORS IN S : ESRX) Filed
08/18 EXPRESS SCRIPTS : Will your prescriptions be covered in 2017?
08/17 EXPRESS SCRIPTS : to fund $175,000 for Christian Hospital's CHAP partnership wit..
08/13 EXPRESS SCRIPTS : A secretive board controls access to prescription drugs for mi..
08/10 RITE AID : Toms River man battles Rite Aid for refund
08/03 NOVO NORDISK A/S : Diabetes drug shunned by Express Scripts Business briefing
08/02DJQuick CFO Exits Can Spell Trouble -- WSJ
08/01DJA Quick CFO Exit Can Spell Trouble
07/29 EXPRESS SCRIPTS HOLDING CO. : Other Events, Financial Statements and Exhibits (f..
More news
Sector news : Drug Retailers - NEC
08/22DJSINOPHARM GROUP : 1st Half Net Profit CNY2.53 Billion, Up 32% on Year
08/17DJTarget Dims Outlook as Sales Struggle
08/09DJPatient Survey Company Press Ganey to Sell Itself to Swedish Firm EQT
08/09DJValeant Posts a Loss and Says It Will Retool
08/05DJAbbVie Sues Amgen Over Humira
More sector news : Drug Retailers - NEC
News from SeekingAlpha
08/24 Tracking Larry Robbins' Glenview Capital Management Portfolio - Q2 2016 Updat..
08/23 Tracking Wallace Weitz's Weitz Investment Management Portfolio - Q2 2016 Upda..
08/12 DIPLOMAT PHARMACY : The Correction Seems Overdone, Overlooking The Performance
08/11 7 INTRIGUING HEALTHCARE GROWTH STOCK : Part 2
08/03 BIOTECH DAILY DIGEST : A Buyout For Biogen? The Rally Continues. Spotlight On Li..
Advertisement
Financials ($)
Sales 2016 101 827 M
EBIT 2016 6 532 M
Net income 2016 2 912 M
Debt 2016 12 635 M
Yield 2016 -
P/E ratio 2016 15,78
P/E ratio 2017 14,30
EV / Sales 2016 0,57x
EV / Sales 2017 0,54x
Capitalization 45 571 M
More Financials
Chart EXPRESS SCRIPTS HOLDING CO
Duration : Period :
Express Scripts Holding Co Technical Analysis Chart | ESRX | US30219G1085 | 4-Traders
Full-screen chart
Technical analysis trends EXPRESS SCRIPTS H...
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 23
Average target price 82,1 $
Spread / Average Target 14%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Timothy C. Wentworth President, Chief Executive Officer & Director
George Paz Chairman
Christine Houston Senior Vice President-Operations
Eric R. Slusser Chief Financial Officer & Executive Vice President
Steven B. Miller Chief Medical Officer & Senior Vice President
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
EXPRESS SCRIPTS HOLDIN..-17.27%45 571
CVS HEALTH CORP-4.61%99 435
WALGREENS BOOTS ALLIAN..-6.77%85 925
MCKESSON CORPORATION-7.32%41 256
CARDINAL HEALTH INC-11.11%25 280
AMERISOURCEBERGEN CORP..-17.32%18 413
More Results